To evaluate opthalmological and dermatological safety of skin care products

Not Applicable

Completed

• Registration Number: CTRI/2021/11/038306
• Lead Sponsor: SERY COSMETICS LLP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-12-08
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. Subject is having valid proof of identity and age.

2. Subject with skin photo type III to V.

3. Skin is healthy (free of eczema, wounds, inflammatory scar).

4. Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the

study, no symptom in the process of an exploratory check-up)

5. Female Subjects in the age group of 18 to 55.

6. Subjects representing varied skin types (representation of all 4 skin types ââ?¬â?? Oily,

Normal, Dry and combination)

7. Subjects representing varied eye conditions (representation of Normal Condition,

8. Sensitive Condition, and Contact Lens Users).

9. Subject Habitual of applying makeup.

10. Subject Habitual waterproof make up.

11. Subjects ready to follow instructions during the study period.

12. Subjects willing to come for regular follow up visits.

Exclusion Criteria

1. Subject is either pregnant/ planning a pregnancy, or lactating.

2. Subject having known history or present condition of allergic response to any

cosmetic products (face/eye)/ known or suspected intolerance to cosmetic

ingredients including fragrance.

3. Subject having any eye infection or allergy/ extremely sensitive eye condition.

4. Subject having any form of cutaneous disease which may Influence the study

result.

5.Previous history of atopy with regards to allergic reactions, irritation or intense

discomfort feelings to topical-use products, cosmetics or medication.

6. Any history of significant dermatological diseases or conditions or medical

conditions.

7. Presence of open sores, pimples, or cysts at the application site

8. Subject having extremely sensitive eye condition.

9. Subject having ocular problems (stye, chalazion, conjunctivitis).

10. Subject having eye infection or allergy.

11. Participation in another clinical study (including cosmetic/ drug studies) or studies

with a similar application site, within 30 days of the screening visit.

12. Any participant who, in the judgment of the Investigator, should not participate in

the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified